Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Targets the appearance of wrinkles
Average body-weight change in the highest-dose group after 48 weeks in the Phase 2 obesity trial
Bunge SA, Wright SB (2007)
AOD-9604 (Anti-Obesity Drug 9604) Description: A fat-burning peptide that stimulates the breakdown of stored fat while preventing new fat deposits, mimicking the fat-loss effects of growth hormone
They are like small proteins
It also suggests getting five or six injections bi-weekly to load the body
US$ 29.14
US$ 27.75
US$ 27.88
